Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Letrozole 2.5Mg Tab
DRUG
3 trials
Sponsors
Weill Medical College of Cornell University
, National Institute of Oncology, Hungary
Conditions
Breast Cancer
Phase 2
CIMER: Combined Immunotherapies in Metastatic ER+ Breast Cancer
Withdrawn
NCT04220476
Weill Medical College of Cornell University
Breast Cancer
Start: 2020-03-04
End: 2028-12-31
Updated: 2020-09-21
Combined Immunotherapies in Metastatic ER+ Breast Cancer
Recruiting
NCT04563507
Weill Medical College of Cornell University
Breast Cancer
Start: 2020-11-12
End: 2028-10-31
Target: 102
Updated: 2025-12-15
Unknown Phase
Neoadjuvant Treatment of Breast Cancer
Not yet recruiting
NCT05131893
National Institute of Oncology, Hungary
Breast Cancer
Start: 2022-03-31
End: 2031-12-31
Target: 300
Updated: 2021-11-23
Related Papers
Abstract P3-04-18: An immunological mechanism of resistance to CDK4/6 inhibitors in breast cancer
Clinical Cancer Research
2025-06-13
733 Immunological mechanisms of resistance to CDK4/CDK6 inhibitors in breast cancer
Regular and Young Investigator Award Abstracts
2021-11-01
2 citations